Shilpa Medicare Share Price

  • 873.75-16.36 (-1.84%)
  • Volume: 1,83,456
  • Closed
  • Last Updated On: 20 Jun, 2025, 03:28 PM IST
Loading...
Shilpa Medicare Share Price
  • 873.75-16.36 (-1.84%)
  • Volume: 1,83,456
Advertisment

Shilpa Medicare share price insights

  • Company's annual revenue growth of 12.92% outperformed its 3 year CAGR of 4.09%. (Source: Consolidated Financials)

  • Company has spent 5.87% of its operating revenues towards interest expenses and 22.75% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Shilpa Medicare Ltd. share price moved down by -1.84% from its previous close of Rs 890.10. Shilpa Medicare Ltd. stock last traded price is 873.75

    Share PriceValue
    Today/Current/Last873.75
    Previous Day890.10889.80

InsightsShilpa Medicare

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    111.01
    EPS - TTM
    (₹)
    8.01
    MCap
    (₹ Cr.)
    8,703.39
    Sectoral MCap Rank
    44
    PB Ratio
    (x)
    3.68
    Div Yield
    (%)
    0.11
    Face Value
    (₹)
    1.00
    Beta

    Beta

    1 Month-0.14
    3 Months0.13
    6 Months0.39
    1 Year0.73
    3 Years0.90

    -0.14
    VWAP
    (₹)
    884.01
    52W H/L
    (₹)
    1,000.00 / 519.50

    Shilpa Medicare Share Price Returns

    1 Day-1.84%
    1 Week-11.37%
    1 Month24.14%
    3 Months32.95%
    1 Year52.67%
    3 Years114.31%
    5 Years71.32%

    ET Stock ScreenersTop Score Companies

    Check whether Shilpa Medicare belongs to analysts' top-rated companies list?

    View Stock Screeners

    Shilpa Medicare Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Shilpa Medicare Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 2 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹540
    • OrganizationAnand Rathi
    • BUY
    • Target₹346
    • OrganizationICICI Securities
    • REDUCE

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy1122
    Buy----
    Hold11--
    Sell----
    Strong Sell----
    # Analysts2222

    Shilpa Medicare Financials

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 12.92% outperformed its 3 year CAGR of 4.09%. (Source: Consolidated Financials)
      • Employee & Interest Expense

        Company has spent 5.87% of its operating revenues towards interest expenses and 22.75% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income338.38320.45348.79301.95294.19
      Total Income Growth (%)5.60-8.1315.512.641.90
      Total Expenses310.91267.43286.07246.02242.13
      Total Expenses Growth (%)16.26-6.5216.281.61-2.07
      EBIT27.4753.0262.7155.9352.06
      EBIT Growth (%)-48.19-15.4612.127.4525.59
      Profit after Tax (PAT)14.5131.7817.9414.0624.50
      PAT Growth (%)-54.3577.1927.56-42.61434.93
      EBIT Margin (%)8.1216.5417.9818.5217.70
      Net Profit Margin (%)4.299.925.144.668.33
      Basic EPS (₹)1.483.251.831.462.82
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income140.24142.21151.15127.57110.70
      Total Income Growth (%)-1.39-5.9118.4815.2428.26
      Total Expenses147.58115.5199.3284.9396.56
      Total Expenses Growth (%)27.7716.3016.93-12.0421.02
      EBIT-7.3426.7151.8442.6414.14
      EBIT Growth (%)-127.49-48.4821.56201.64116.96
      Profit after Tax (PAT)-5.1516.1230.4928.359.74
      PAT Growth (%)-131.97-47.137.55191.12261.06
      EBIT Margin (%)-5.2318.7834.2933.4212.77
      Net Profit Margin (%)-3.6811.3420.1722.228.80
      Basic EPS (₹)-0.531.653.122.941.12
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue1,309.571,159.771,067.511,159.77931.27
      Total Revenue Growth (%)12.928.64-7.9524.540.69
      Total Expenses1,157.891,106.791,101.981,062.63795.32
      Total Expenses Growth (%)4.620.443.7033.617.99
      Profit after Tax (PAT)78.2931.87-32.4860.66147.78
      PAT Growth (%)145.63--153.54-58.95-5.36
      Operating Profit Margin (%)17.6612.572.3012.0717.51
      Net Profit Margin (%)6.082.76-3.095.2916.39
      Basic EPS (₹)8.043.67-3.747.2618.13
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue561.18398.90316.35397.81289.30
      Total Revenue Growth (%)40.6826.10-20.4837.51-64.60
      Total Expenses408.20350.36359.08379.14252.03
      Total Expenses Growth (%)16.51-2.43-5.2950.43-58.02
      Profit after Tax (PAT)69.8026.9457.19140.99184.39
      PAT Growth (%)159.13-52.90-59.43-23.54-4.81
      Operating Profit Margin (%)33.4321.23-8.847.7616.85
      Net Profit Margin (%)14.628.6923.0839.4971.73
      Basic EPS (₹)7.163.106.5916.2422.62

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,310.713,093.202,902.382,875.502,637.55
      Total Assets Growth (%)7.036.570.939.0232.80
      Total Liabilities947.011,293.251,128.031,064.351,170.03
      Total Liabilities Growth (%)-26.7714.655.98-9.0376.03
      Total Equity2,363.701,799.961,774.361,811.151,467.50
      Total Equity Growth (%)31.321.44-2.0323.4211.05
      Current Ratio (x)1.461.260.981.451.52
      Total Debt to Equity (x)0.250.520.450.370.49
      Contingent Liabilities0.0095.55186.39103.8647.85
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,006.662,418.582,517.362,896.122,517.39
      Total Assets Growth (%)24.32-3.92-13.0815.0424.54
      Total Liabilities306.07275.87399.77830.45879.56
      Total Liabilities Growth (%)10.95-30.99-51.86-5.5854.89
      Total Equity2,700.592,142.722,117.582,065.671,637.83
      Total Equity Growth (%)26.041.192.5126.1212.69
      Current Ratio (x)2.101.672.631.941.65
      Total Debt to Equity (x)0.040.070.140.090.40
      Contingent Liabilities0.00655.24510.05374.38207.79

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 199.08 cr for investing activities which is an YoY increase of 19.51%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities132.18135.34226.17105.1347.07
      Net Cash used in Investing Activities-199.08-166.58-278.48-285.50-404.28
      Net Cash flow from Financing Activities62.6546.7845.8082.86436.37
      Net Cash Flow-3.2311.35-6.51-97.5179.03
      Closing Cash & Cash Equivalent28.5230.4318.8325.34123.34
      Closing Cash & Cash Equivalent Growth (%)-6.2561.62-25.71-79.46176.78
      Total Debt/ CFO (x)4.446.913.526.4915.38
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-19.068.032.08173.8769.63
      Net Cash used in Investing Activities-433.29155.82-94.80-378.97-238.13
      Net Cash flow from Financing Activities450.09-163.0787.6897.23255.58
      Net Cash Flow-0.040.78-5.04-107.8887.08
      Closing Cash & Cash Equivalent4.423.132.107.13115.01
      Closing Cash & Cash Equivalent Growth (%)41.4048.98-70.58-93.80308.06
      Total Debt/ CFO (x)-5.6117.74138.111.129.38

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)3.301.76-1.823.329.99
      Return on Capital Employed (%)8.616.031.146.107.75
      Return on Assets (%)2.361.03-1.112.105.60
      Interest Coverage Ratio (x)4.502.752.045.307.22
      Asset Turnover Ratio (x)0.400.380.360.1334.16
      Price to Earnings (x)83.33126.58-61.3557.1418.42
      Price to Book (x)2.732.211.121.891.84
      EV/EBITDA (x)20.6719.4023.0318.7315.63
      EBITDA Margin (%)26.4421.9411.3919.0323.50
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)2.581.252.706.8211.25
      Return on Capital Employed (%)5.743.00-0.961.212.12
      Return on Assets (%)2.321.112.274.867.32
      Interest Coverage Ratio (x)31.566.691.186.9110.80
      Asset Turnover Ratio (x)0.180.130.090.130.11
      Price to Earnings (x)93.46149.2534.8424.5114.77
      Price to Book (x)2.401.870.941.671.66
      EV/EBITDA (x)31.6035.9192.2557.9649.67
      EBITDA Margin (%)43.6637.259.9417.5225.52

    Financial InsightsShilpa Medicare

    • Income (P&L)
    • Cash Flow
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 12.92% outperformed its 3 year CAGR of 4.09%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 5.87% of its operating revenues towards interest expenses and 22.75% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 199.08 cr for investing activities which is an YoY increase of 19.51%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Shilpa Medicare Share Price Forecast

    • Get multiple analysts’ prediction on Shilpa Medicare

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Shilpa Medicare

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Shilpa Medicare

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Shilpa Medicare Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Shilpa Medicare Peer Comparison

    Peers InsightsShilpa Medicare

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Shilpa Medicare Shareholding Pattern

      • Loading...
        Showing Shilpa Medicare Shareholding as on Mar 2025
        CategoryMar 2025Dec 2024Sep 2024Jun 2024
        Promoters44.2344.2344.3344.39
        Pledge7.927.927.9090.41
        FII10.969.909.599.08
        DII7.558.278.187.61
        Mutual Funds4.054.895.095.03
        Others37.2637.6037.9038.92
      • Showing Shareholding as on Mar 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters4,32,49,71544.23 %0.00
        Pledge34,25,0007.92 %0.00
        FII1,07,30,61010.96 %1.06
        DII73,80,2557.55 %-0.71
        MF39,60,1414.05 %-0.83
        Others3,64,30,32837.26 %-0.34

      Shilpa Medicare MF Ownership

      MF Ownership as on 31 May 2025

      Shilpa Medicare Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        May 26, 2025May 19, 2025Board MeetingAudited Results & Final Dividend
        Feb 10, 2025Feb 03, 2025Board MeetingQuarterly Results
        Nov 13, 2024Nov 04, 2024Board MeetingQuarterly Results
        Aug 08, 2024Jul 31, 2024Board MeetingQuarterly Results
        May 23, 2024May 16, 2024Board MeetingAudited Results & Final Dividend
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final110%1.1Sep 19, 2022May 23, 2022
        Final110%1.1Sep 20, 2021May 31, 2021
        Interim110%1.1Mar 16, 2020Mar 03, 2020
        Final100%1.0Sep 12, 2019May 27, 2019
        Final100%1.0-May 26, 2025
      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsNov 06, 2015Nov 09, 2015Aug 12, 2015Split: Old FV2.0| New FV:1.0
        BonusJul 16, 2013-May 29, 2013Bonus Ratio: 1 share(s) for every 2 shares held
        SplitsSep 28, 2007Oct 08, 2007Apr 26, 2007Split: Old FV10.0| New FV:2.0

      About Shilpa Medicare

      Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 8,634.94 Crore) operating in Pharmaceuticals sector. Shilpa Medicare Ltd. key Products/Revenue Segments include Formulations, Sale of services, Traded Goods, Power for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • OI

        Omprakash Inani

        Chairman
        VC

        Vishnukant C Bhutada

        Managing Director
        KS

        Kalakota Sharath Reddy

        Whole Time Director
        AB

        Anita Bandyopadhyay

        Independent Woman Director
        Show More
      • Bohara Bhandari Bung & Associates LLP
        Brahmayya & Co.

      FAQs about Shilpa Medicare share

      • 1. What is Shilpa Medicare share price and what are the returns for Shilpa Medicare share?
        Shilpa Medicare share price is Rs 882.65 as on 20 Jun, 2025, 03:14 PM IST. Shilpa Medicare share price is down by 0.84% based on previous share price of Rs 917.9. Shilpa Medicare share price trend:
        • Last 1 Month: Shilpa Medicare share price moved up by 25.40%
        • Last 3 Months: Shilpa Medicare share price moved up by 34.30%
        • Last 12 Months: Shilpa Medicare share price moved up 54.23%
        • Last 3 Years: Shilpa Medicare Share price moved up by 116.50%
      • 2. What are the returns for Shilpa Medicare share?
        Return Performance of Shilpa Medicare Shares:
        • 1 Week: Shilpa Medicare share price moved down by 10.46%
        • 1 Month: Shilpa Medicare share price moved up by 25.40%
        • 3 Month: Shilpa Medicare share price moved up by 34.30%
        • 6 Month: Shilpa Medicare share price moved up by 8.55%
      • 3. What's the market capitalization of Shilpa Medicare?
        Market Capitalization of Shilpa Medicare stock is Rs 8,634.94 Cr.
      • 4. What is 52 week high/low of Shilpa Medicare share price?
        In last 52 weeks Shilpa Medicare share had a high price of Rs 1,000.00 and low price of Rs 519.50
      • 5. What is the PE & PB ratio of Shilpa Medicare?
        The PE ratio of Shilpa Medicare stands at 111.18, while the PB ratio is 3.68.

      Trending in Markets

      Top Gainers As on 03:23 PM | 20 Jun 2025

      Waaree Energies2,997.50
      326.31 (12.22%)
      BEML4,662.60
      374.81 (8.75%)
      Endurance Tech.2,579.80
      164.81 (6.83%)
      RattanIndia Infra58.79
      3.68 (6.68%)
      KFIN Technologies1,277.70
      79.71 (6.66%)

      Top Losers As on 03:24 PM | 20 Jun 2025

      Concord Biotech Ltd.1,828.80
      -144.50 (-7.33%)
      Eris Lifesciences1,608.80
      -127.00 (-7.32%)
      AstraZeneca8,823.00
      -587.50 (-6.25%)
      Intellect Design1,074.80
      -67.11 (-5.88%)
      Gillette India9,821.00
      -569.00 (-5.48%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times